People with prostate cancer have been offered new hope after researchers at University of Pennsylvania discovered a molecule that appears to target the tumours. The researchers found that the "monoclonal" antibody seems to act against the disease in both its early and advanced stages.

Besides attacking the disease directly, it also helps the immune system to identify and destroy cancer cells.

(Continue reading in the Telegraph)